Ophthalmic Antifungals
Key Points
- Natamycin is the primary FDA-approved ophthalmic antifungal agent.
- Therapy targets fungal blepharitis, conjunctivitis, and keratitis from susceptible organisms.
- Because natamycin is a suspension, vigorous shaking before each dose is required.
- Lack of improvement after about 10 days suggests alternate diagnosis or resistance and requires reassessment.
- Hypersensitivity monitoring and strict administration adherence are high-priority nursing tasks.
Class Overview
Topical ocular antifungals treat filamentous and yeast-related eye infections while minimizing systemic exposure. Natamycin has mainly local action, low systemic absorption, and prolonged corneal-surface contact.
Prototype Dosing
| Drug | Typical Adult Ophthalmic Dosing | Main Indications |
|---|---|---|
| Natamycin 5% suspension | 1 drop every 1-2 hours for 3-4 days, then 1 drop 6-8 times daily for 14-21 days | Fungal blepharitis, conjunctivitis, keratitis |
Dose tapering at about 4- to 7-day intervals may be considered to confirm pathogen control while preventing relapse.
Adverse Effects and Contraindications
- Ocular irritation/discomfort, conjunctival hyperemia, lacrimation
- Vision changes or corneal opacity
- Dyspnea/chest discomfort and allergic-pattern reactions in severe cases
- Contraindication: hypersensitivity to formulation ingredients
Nursing Assessment and Interventions
- Confirm proper administration and adherence; missed doses can delay fungal clearance.
- Monitor therapeutic response: reduced redness, pain, tearing, and improving visual acuity.
- Escalate urgently for hypersensitivity signs (hives, facial/lip/tongue swelling, severe eye pain).
- If no response by about day 10, notify prescriber for alternate pathogen/resistance reassessment.
Client Education
- Shake bottle well before each dose to distribute suspension particles.
- Use no-touch drop technique and maintain strict hand hygiene.
- Continue therapy exactly as prescribed, including taper adjustments when ordered.
- Report worsening pain, redness, breathing symptoms, or new vision changes immediately.
Related Concepts
- ophthalmic-medication-administration - Technique and contamination prevention.
- antifungal-medications - Broader antifungal class mechanisms and risks.
- ophthalmic-antibiotics - Superinfection and differential-treatment context.
- eye-assessment-visual-acuity-and-common-abnormalities - Follow-up visual assessment during therapy.